3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
40
Biopsy
32
Magnetic Resonance Spectroscopy
26
pembrolizumab
20
Nivolumab
10
trastuzumab deruxtecan
9
Paclitaxel
9
Carboplatin
9
Radiosurgery
7
Irinotecan
7
Gemcitabine
7
X-Rays
6
Pemetrexed
6
Leucovorin
6
Ipilimumab
6
Fulvestrant
6
Fluorouracil
6
Cetuximab
6
Bevacizumab
6
palbociclib
5
Taxes
5
Oxaliplatin
5
Cisplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Letrozole
4
CTLA-4 Antigen
4
ribociclib
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.